CIK 0001850270
- Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- EIN
- 981586514
- Phone
- +1 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 4 Insider Changes in Ownership
- 4 Planned sale Chief Regulatory Officer sold 103,480 shares at $3.02 ($312,510)
- 4 Conversion Director acquired 3,823,996 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 387,393 shares at $0.71 ($276,366)
- 4 Open-market buy 10% owner bought 25,000 shares at $0.75 ($18,690)
- 4 Open-market buy 10% owner bought 100,000 shares at $0.75 ($74,820)
- 4 Open-market buy 10% owner bought 736,105 shares at an average $0.71 ($520,599)
- 4 Open-market buy 10% owner bought 1,034,118 shares at $0.61 ($628,847)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 532,535 shares (conversion)
Page 2 of 8 · 153 filings